M&A Deal Summary |
|
|---|---|
| Date | 2024-06-20 |
| Target | Occy |
| Sector | Consumer Products |
| Buyer(s) | Crescita Therapeutics |
| Deal Type | Special Situations/Distressed |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2016 |
| Sector | Life Science |
| Employees | 62 |
| Revenue | 20M CAD (2024) |
Crescita Therapeutics is a drug development company that owns topical products for treating medical conditions in dermatology and pain. Crescita Therapeutics was founded in 2016 and is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Consumer Products M&A | 2 of 2 |
| Type: Special Situations/Distressed M&A Deals | 1 of 1 |
| State: Quebec M&A | 2 of 2 |
| Country: Canada M&A | 2 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-01 |
INTEGA Skin Sciences
Montreal, Quebec, Canada INTEGA Skin Sciences, Inc. is a dermatology company which develops, manufactures, sells and markets science-based quality skin care products. |
Buy | $8M |